Degradation of Cyclin-Dependent Kinase 9/Cyclin T1 by Optimized Microtubule-Associated Protein 1 Light Chain 3 Beta-Recruiting Coumarin Analogs
Journal of Medicinal Chemistry · 28.09.2023 · 66 (18) · 12877-12893
DOI: 10.1021/acs.jmedchem.3c00828 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 06.09.2023. Verfasst von Yanping Zeng und 7 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zu-Chong-Zhi Road, Zhangjiang Hi-Tech P…. Hauptthemen laut MEDLINE: Cyclin-Dependent Kinase 9, Microtubule-Associated Proteins. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: State Key Laboratory of Drug Research, Science and Technology Commission of Shanghai Municipality.
Abstract (Originalsprache)
Autophagy is an efficient and attractive protein degradation pathway in addition to the ubiquitin-proteasome system. Herein, systematic optimization of coumarin analogs linked with the CDK9 inhibitor SNS-032 is reported that may bind to cyclin-dependent kinase 9 (CDK9) and microtubule-associated protein 1 light chain 3 beta (LC3B) simultaneously, which leads to the selective autophagic degradation of targeted CDK9/cyclin T1 and is different from the PROTAC degrader THAL-SNS-032. Further mechanism studies revealed an autophagy-lysosome pathway, where the degraders possibly formed a ternary complex with CDK9 and LC3B. In addition, degrader 10 showed antitumor efficacy in vivo. Our work optimized a potent LC3B recruiter and demonstrated the feasibility of autophagy-tethering compounds (ATTECs), which could be applied for the degradation of diverse intracellular pathogenic proteins to treat related diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zu-Chong-Zhi Road, Zhangjiang Hi-Tech Park, Shanghai 201203, China.
- University of Chinese Academy of Sciences, 19 Yuquan Road, Beijing 100049, China.
- Division of Anti-Tumor Pharmacology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
- Nanjing University of Chinese Medicine, 138 Xianlin Road, Nanjing 210046, China.
- Shandong Laboratory of Yantai Drug Discovery, Bohai Rim Advanced Research Institute for Drug Discovery, Yantai 264117, Shandong, China.
- State Key Laboratory of Chemical Biology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
ORCID-Profile: Youhong Hu
Förderung
- State Key Laboratory of Drug Research
- Science and Technology Commission of Shanghai Municipality
Zitieren
APA
Zeng, Y., Xiao, J., Xu, Y., Wei, F., Tian, L., Gao, Y., Chen, Y., & Hu, Y. (2023). Degradation of Cyclin-Dependent Kinase 9/Cyclin T1 by Optimized Microtubule-Associated Protein 1 Light Chain 3 Beta-Recruiting Coumarin Analogs. Journal of Medicinal Chemistry, 66(18), 12877-12893. https://doi.org/10.1021/acs.jmedchem.3c00828
Vancouver
Zeng Y, Xiao J, Xu Y, Wei F, Tian L, Gao Y, et al. Degradation of Cyclin-Dependent Kinase 9/Cyclin T1 by Optimized Microtubule-Associated Protein 1 Light Chain 3 Beta-Recruiting Coumarin Analogs. Journal of Medicinal Chemistry. 2023;66(18):12877-12893. doi:10.1021/acs.jmedchem.3c00828
BibTeX
@article{Zeng2023,
author = {Zeng, Yanping and Xiao, Jian and Xu, Yuanxin and Wei, Fan and Tian, Lina and Gao, Yinglei and Chen, Yi and Hu, Youhong},
title = {Degradation of Cyclin-Dependent Kinase 9/Cyclin T1 by Optimized Microtubule-Associated Protein 1 Light Chain 3 Beta-Recruiting Coumarin Analogs},
journal = {Journal of Medicinal Chemistry},
year = {2023},
volume = {66},
number = {18},
pages = {12877--12893},
doi = {10.1021/acs.jmedchem.3c00828}
}
EUVIMED